Applied BioCode Corporation
TWSE:6598.TW
22 (TWD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -164.199 | -184.71 | -165.176 | -103.472 | -280.049 | -268.281 | -263.436 | -192.032 | -22.664 | -76.094 | -209.265 |
| Depreciation & Amortization
| 62.684 | 56.512 | 50.959 | 43.595 | 32.808 | 16.633 | 13.06 | 11.419 | 9.608 | 7.113 | 5.217 |
| Deferred Income Tax
| -196.32 | 0 | 5.896 | -0.605 | -4.844 | 0.999 | 1.363 | 1.084 | -196.934 | -85.785 | 127.895 |
| Stock Based Compensation
| 5.541 | 7.727 | 8.565 | 13.533 | 6.883 | 11.169 | 1.747 | 1.871 | 0.816 | 1.081 | 0.051 |
| Change In Working Capital
| -110.317 | 266.003 | -51.776 | -72.311 | -73.456 | -47.492 | -4.015 | -265.702 | 2.361 | 19.989 | -24.474 |
| Accounts Receivables
| 19.477 | -3.367 | -24.001 | -25.37 | -18.426 | 0.567 | -4.519 | -1.945 | 0 | 0 | 0 |
| Inventory
| -78.745 | -25.896 | -13.383 | -65.56 | -39.691 | -51.267 | -8.998 | -4.529 | 3.962 | -3.868 | -0.376 |
| Accounts Payables
| -6.143 | -0.701 | -18.174 | 18.02 | -2.331 | 11.344 | -3.613 | -1.497 | 0 | 0 | 0 |
| Other Working Capital
| -44.906 | 295.967 | 3.782 | 0.599 | -13.008 | 3.775 | 4.983 | -261.173 | -1.601 | 23.857 | -24.098 |
| Other Non Cash Items
| 197.526 | 0.339 | -0.241 | -27.481 | 4.82 | 0.257 | 0.923 | -5.605 | -2.424 | 4.892 | 8.65 |
| Operating Cash Flow
| -205.085 | 145.871 | -151.773 | -146.741 | -313.838 | -286.715 | -250.358 | -448.965 | -209.237 | -128.804 | -91.926 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -6.394 | -22.142 | -16.268 | -27.954 | -24.343 | -18.627 | -5.668 | -5.465 | -28.84 | -5.825 | -12.644 |
| Acquisitions Net
| 0 | 0 | 0 | -383.607 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -191.622 | 0 | 0 | 121.326 | -121.326 | -0.653 | 332.744 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 383.607 | 0 | 0 | 332.744 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -191.622 | 0 | -0.12 | -6.808 | -0.605 | -4.613 | 332.453 | -359.583 | 0 | 0.02 | 0 |
| Investing Cash Flow
| -198.016 | -22.142 | -16.388 | 86.564 | -146.274 | -23.893 | 327.076 | -5.465 | -28.84 | -5.805 | -12.644 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -15.744 | -15.139 | -15.526 | -60.212 | -120.424 | -0.001 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.043 | 0.281 | 1.338 | 704.597 | 390.73 | 407.666 | 140.402 | 407.293 | 158.354 | 277.529 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | -0.016 | -0.137 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -15.744 | -14.858 | -14.188 | 12.377 | 168.935 | 407.665 | 140.386 | 542.875 | -0.273 | 1.709 | 0 |
| Financing Cash Flow
| -15.701 | -14.858 | -14.188 | 656.762 | 439.241 | 407.666 | 140.386 | 407.156 | 158.081 | 279.238 | 0 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0.674 | 76.381 | -19.491 | -51.351 | -25.479 | 4.786 | -25.288 | 3.553 | 12.274 | 17.26 | 4.81 |
| Net Change In Cash
| -418.128 | 185.252 | -201.84 | 545.234 | -46.35 | 101.844 | 191.816 | -43.721 | -67.722 | 161.889 | -99.76 |
| Cash At End Of Period
| 413.194 | 831.322 | 646.07 | 847.91 | 302.676 | 349.026 | 247.182 | 55.366 | 134.943 | 202.665 | 40.776 |